Skip to main content
Filter By
Timeline Stories
Important Date

Business Insider reveals Hunter Biden's gallery sold art to major Democratic donor and Biden-appointed commissioner Elizabeth Hirsh Naftali.   Naftali was appointed by President Biden to the Commission for the Preservation of America's Heritage Abroad.   This is the same Commission President Obama appointed Eric Schwerin, Hunter Biden's longtime business associate, to in ...

Press Release
Comer, Greene Press DOJ on Mishandling of Hunter Biden Victims’ Rights

“DOJ opted to leave victims out of the conversation” WASHINGTON—House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) and Rep. Marjorie Taylor Greene (R-Ga.) are today pressing for information from the Department of Justice (DOJ) related to DOJ’s potential failure to uphold the rights of victims who were sexually exploited by Hunter Biden. The Crime Victims’ Rights Act (CRVA) and Mandatory Victim Restitution Act (MRVA) protect victims, ...

Timeline Stories
Important Date

Senator Chuck Grassley released an unclassified FBI-generated record describing an alleged criminal scheme involving then-Vice President Joe Biden and a Ukrainian business executive. Senator Grassley acquired the record, an FD-1023, via legally protected disclosures by Justice Department whistleblowers.

Press Release
Comer Statement on Then-VP Biden’s Involvement with Family’s Foreign Business Schemes

WASHINGTON—House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) issued the following statement about

Letter
Letter to Troy Miller

Press Release
Comer Announces Hearing to Examine ONDCP’s Effort to Combat America’s Drug Overdose Crisis

WASHINGTON – House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) will hold a hearing titled “Oversight and Reauthorization of the Office of National Drug Control Policy (ONDCP).” This full committee hearing will examine ONDCP’s role in combatting the drug overdose crisis at a time when the toll on American communities is especially high. In addition, the hearing will enable members to conduct oversight over ONDCP’s role and activities, as ...

Press Release
Wenstrup to Hold Hearing on Consequences of COVID-19 Vaccine Mandates

WASHINGTON — Select Subcommittee on the Coronavirus Pandemic Chairman Brad Wenstrup (R-Ohio) will hold a hearing titled “Because I Said So: Examining the Science and Impact of COVID-19 Vaccine Mandates” to evaluate the necessity and effectiveness of overreaching COVID-19 vaccine mandates and consider the erosion of public trust that stemmed from coercive vaccination policies. On August 24, 2021, the federal government issued its first COVID-19 vaccine mandate, which was ...

Press Release
Comer & Green Probe CBP Over Allegations of Retaliation Against a Witness in Committees’ Biden Border Crisis Investigation

WASHINGTON—House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) and House Committee on Homeland Security Chairman Mark Green (R-Tenn.) are probing allegations made by a credible whistleblower that U.S. Customs and Border Protection (CBP) officials have retaliated against a witness in the committees’ investigation of President Biden’s border crisis. In a letter to the Senior Official Performing the Duties of the Commissioner Troy A. Miller, Chairmen Comer and ...

Press Release
National Security Subcommittee to Hold Hearing on Unidentified Anomalous Phenomena

WASHINGTON—The Subcommittee on National Security, the Border, and Foreign Affairs will hold a hearing titled “Unidentified Anomalous Phenomena: Implications on National Security, Public Safety, and Government Transparency.” The subcommittee hearing will explore firsthand accounts of unidentified anomalous phenomena (UAP) and assess the federal government’s transparency and accountability regarding UAPs’ possible threats to U.S. national ...

Press Release
McClain to Hold Hearing on FDA Refusal to Regulate Hemp and CBD Products

WASHINGTON—Subcommittee on Health Care and Financial Services Chairwoman Lisa McClain (R-Mich.) today announced a hearing titled “Hemp in the Modern World: The Yearslong Wait for FDA Action” to examine the Food and Drug Administration (FDA)’s failure to regulate hemp-derived and cannabidiol (CBD) products under existing authorities for years. “The FDA has failed for too long to do its job to ensure the safety of legalized hemp-derived products. Without these regulations, ...